Fig. 8
From: Comprehensive analysis of MAGE-A10 in pan-cancer and its validation in gastric cancer
Correlation analysis of MAGEA10 with anti-tumor immunity. (A) Evaluating the efficacy of MAGEA10 in predicting IC B treatment compared to standardized biomarkers. (B) Correlation between MAGEA10 and CTL dysfunction in pan-cancer analyzed using the TIDE database. (C) Prognostic analysis of MAGEA10 expression and CTL infiltration in GSE1427-AML. (D) Prognostic analysis of MAGEA10 expression and CTL infiltration in GSE13507-Bladder cancer.
